Treatment of Rectal Cancer-Induced Disseminated Carcinomatosis of the Bone Marrow with FOLFOX plus Cetuximab and Panitumumab

Treatment of Rectal Cancer-Induced Disseminated Carcinomatosis of the Bone Marrow with FOLFOX plus Cetuximab and Panitumumab

Disseminated carcinomatosis of the bone marrow (DCBM) in colorectal cancer is an extremely rare complication with a poor prognosis. Here, we report a case of DCBM due to rectal cancer successfully treated with a combination of FOLFOX and an anti-epidermal growth factor receptor (EGFR) agent. The pat...

Full description

Bibliographic Details
Main Authors: Takehito Ehara, Masato Kitazawa, Nao Hondo, Shugo Takahata, Yuta Yamamoto, Makoto Koyama, Motohiro Okumura, Satoshi Nakamura, Shigeo Tokumaru, Futoshi Muranaka, Yusuke Miyagawa, Yuji Soejima
Format: Article
Language:English
Published: Karger Publishers 2020-02-01
Series:Case Reports in Oncology
Subjects:
disseminated carcinomatosis of the bone marrow
cetuximab
colorectal cancer
panitumumab
Online Access:https://www.karger.com/Article/FullText/505323

Internet

https://www.karger.com/Article/FullText/505323

Similar Items